{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:04Z","timestamp":1786120264286,"version":"build-2736575974"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5,27]]},"DOI":"10.1097\/tp.0b013e31824e75d7","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T10:16:33Z","timestamp":1333534593000},"page":"997-1005","source":"Crossref","is-referenced-by-count":24,"title":["Combined Costimulatory and Leukocyte Functional Antigen-1 Blockade Prevents Transplant Rejection Mediated by Heterologous Immune Memory Alloresponses"],"prefix":"10.1097","volume":"93","author":[{"given":"William H.","family":"Kitchens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Haridas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maylene E.","family":"Wagener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy L.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210129","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/381434a0","article-title":". Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.","volume":"381","author":"Larsen","year":"1996","journal-title":"Nature"},{"key":"R2-7-20210129","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1600-6143.2006.01259.x","article-title":". A new look at blockade of T-cell costimulation: A therapeutic strategy for long-term maintenance immunosuppression.","volume":"6","author":"Larsen","year":"2006","journal-title":"Am J Transplant"},{"key":"R3-7-20210129","first-page":"2935","article-title":"Transplant tolerance through costimulation blockadeAre we there yet Front B","volume":"12","author":"Vadivel","year":"2007","journal-title":"iosci"},{"key":"R4-7-20210129","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2741\/2829","article-title":"Costimulation blockade: Towards clinical application.","volume":"13","author":"Weaver","year":"2008","journal-title":"Front Biosci"},{"key":"R5-7-20210129","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":". A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"R6-7-20210129","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":". A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study).","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"key":"R7-7-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.tp.0000226082.17507.da","article-title":"The impact of memory T cells on rejection and the induction of tolerance.","volume":"82","author":"Brook","year":"2006","journal-title":"Transplantation"},{"key":"R8-7-20210129","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1034\/j.1600-6143.2002.20603.x","article-title":"Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice.","volume":"2","author":"Valujskikh","year":"2002","journal-title":"Am J Transplant"},{"key":"R9-7-20210129","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.4049\/jimmunol.169.8.4667","article-title":". Allograft rejection by primedmemory CD8 T cells is CD154 blockade resistant: Therapeutic implications for sensitized transplant recipients.","volume":"169","author":"Zhai","year":"2002","journal-title":"J Immunol"},{"key":"R10-7-20210129","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.4049\/jimmunol.152.6.2675","article-title":"Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells.","volume":"152","author":"Croft","year":"1994","journal-title":"J Immunol"},{"key":"R11-7-20210129","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1172\/JCI8082","article-title":". Asialo GM1() CD8() T cells play a critical role in costimulation blockade-resistant allograft rejection.","volume":"104","author":"Trambley","year":"1999","journal-title":"J Clin Invest"},{"key":"R12-7-20210129","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/j.1600-6143.2005.00958.x","article-title":". Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients.","volume":"5","author":"Augustine","year":"2005","journal-title":"Am J Transplant"},{"key":"R13-7-20210129","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.4049\/jimmunol.163.4.2267","article-title":". Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes.","volume":"163","author":"Heeger","year":"1999","journal-title":"J Immunol"},{"key":"R14-7-20210129","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/01.tp.0000258730.75137.39","article-title":". Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection.","volume":"83","author":"Poggio","year":"2007","journal-title":"Transplantation"},{"key":"R15-7-20210129","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI200317477","article-title":". Heterologous immunity provides a potent barrier to transplantation tolerance.","volume":"111","author":"Adams","year":"2003","journal-title":"J Clin Invest"},{"key":"R16-7-20210129","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":". Allo-HLA reactivity of virus-specific memory T cells is common.","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"R17-7-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-6143.2011.03762.x","article-title":". Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8() memory T cells.","volume":"12","author":"Kitchens","year":"2012","journal-title":"Am J Transplant"},{"key":"R18-7-20210129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.immunol.22.012703.104649","article-title":". Integrins and T cell-mediated immunity.","volume":"22","author":"Pribila","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"R19-7-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevImmunol.v29.i2.10","article-title":"Integrin function in T-cell homing to lymphoid and nonlymphoid sites: Getting there and staying there.","volume":"29","author":"Denucci","year":"2009","journal-title":"Crit Rev Immunol"},{"key":"R20-7-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1242\/jcs.019117","article-title":". Integrins in immunity.","volume":"122","author":"Evans","year":"2009","journal-title":"J Cell Sci"},{"key":"R21-7-20210129","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1034\/j.1600-065X.2002.18610.x","article-title":"The immunological synapse: Integrins take the stage.","volume":"186","author":"Sims","year":"2002","journal-title":"Immunol Rev"},{"key":"R22-7-20210129","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1582-4934.2009.00811.x","article-title":"Leukocyte-endothelial interactions in inflammation.","volume":"13","author":"Langer","year":"2009","journal-title":"J Cell Mol Med"},{"key":"R23-7-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-065X.2007.00536.x","article-title":"Integrin modulation and signaling in leukocyte adhesion and migration.","volume":"218","author":"Rose","year":"2007","journal-title":"Immunol Rev"},{"key":"R24-7-20210129","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nrd3266","article-title":"Integrins as therapeutic targets: Lessons and opportunities.","volume":"9","author":"Cox","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"R25-7-20210129","first-page":"289","article-title":"Therapeutic anti-integrin (alpha4 and alphaL) monoclonal antibodies: Two-edged swords I","volume":"116","author":"Gonzalez-Amaro","year":"2005","journal-title":"mmunology"},{"key":"R26-7-20210129","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00007890-199608150-00019","article-title":". Acceptance of primary skin graft after treatment with anti-intercellular adhesion molecule-1 and anti-leukocyte function-associated antigen-1 monoclonal antibodies in mice.","volume":"62","author":"Isobe","year":"1996","journal-title":"Transplantation"},{"key":"R27-7-20210129","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.healun.2004.09.004","article-title":". Perturbation of leukocyte function-associated antigen-1intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.","volume":"24","author":"Grazia","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R28-7-20210129","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.4049\/jimmunol.153.12.5810","article-title":". Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies.","volume":"153","author":"Isobe","year":"1994","journal-title":"J Immunol"},{"key":"R29-7-20210129","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1097\/00007890-199305000-00051","article-title":". The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection.","volume":"55","author":"Paul","year":"1993","journal-title":"Transplantation"},{"key":"R30-7-20210129","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0039-6060(97)90057-X","article-title":". Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection.","volume":"121","author":"Miwa","year":"1997","journal-title":"Surgery"},{"key":"R31-7-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1385\/IJGC:26:1:23","article-title":". Preventing effect of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies on murine islet allograft rejection.","volume":"26","author":"Arai","year":"1999","journal-title":"Int J Pancreatol"},{"key":"R32-7-20210129","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.164.7.3627","article-title":". Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4.","volume":"164","author":"Nicolls","year":"2000","journal-title":"J Immunol"},{"key":"R33-7-20210129","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/00007890-199710150-00005","article-title":". Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.","volume":"64","author":"Nishihara","year":"1997","journal-title":"Transplantation"},{"key":"R34-7-20210129","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/00007890-200106150-00011","article-title":". Alpha4 integrin in islet allograft rejection.","volume":"71","author":"Stegall","year":"2001","journal-title":"Transplantation"},{"key":"R35-7-20210129","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0039-6060(05)80346-0","article-title":". Prolongation of islet allograft survival with an antibody to vascular cell adhesion molecule 1.","volume":"118","author":"Stegall","year":"1995","journal-title":"Surgery"},{"key":"R36-7-20210129","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1172\/JCI43895","article-title":". LFA-1-specific therapy prolongs allograft survival in rhesus macaques.","volume":"120","author":"Badell","year":"2010","journal-title":"J Clin Invest"},{"key":"R37-7-20210129","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/01.TP.0000092525.17025.D0","article-title":". The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.","volume":"76","author":"Berney","year":"2003","journal-title":"Transplantation"},{"key":"R38-7-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0966-3274(02)00014-X","article-title":". CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely.","volume":"10","author":"Corbascio","year":"2002","journal-title":"Transpl Immunol"},{"key":"R39-7-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00007890-200201270-00024","article-title":". CTLA4ig induces long-term graft survival of allogeneic skin grafts and totally inhibits T-cellproliferation in LFA-1-deficient mice.","volume":"73","author":"Malm","year":"2002","journal-title":"Transplantation"},{"key":"R40-7-20210129","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.4049\/jimmunol.169.9.4831","article-title":". CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways.","volume":"169","author":"Nicolls","year":"2002","journal-title":"J Immunol"},{"key":"R41-7-20210129","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1046\/j.1600-6143.2003.00201.x","article-title":". Targeting LFA-1 synergizes with CD40CD40L blockade for suppression of both CD4-dependent and CD8-dependent rejection.","volume":"3","author":"Wang","year":"2003","journal-title":"Am J Transplant"},{"key":"R42-7-20210129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.it.2005.04.011","article-title":"The bone marrow: A nest for migratory memory T cells.","volume":"26","author":"Di Rosa","year":"2005","journal-title":"Trends Immunol"},{"key":"R43-7-20210129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.immuni.2005.01.008","article-title":". Bone marrow is a major reservoir and site of recruitment for central memory CD8 T cells.","volume":"22","author":"Mazo","year":"2005","journal-title":"Immunity"},{"key":"R44-7-20210129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.193.6.741","article-title":". Conditional vascular cell adhesion molecule 1 deletion in mice: Impaired lymphocyte migration to bone marrow.","volume":"193","author":"Koni","year":"2001","journal-title":"J Exp Med"},{"key":"R45-7-20210129","doi-asserted-by":"crossref","first-page":"86ra51","DOI":"10.1126\/scitranslmed.3002093","article-title":". Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates.","volume":"3","author":"Nadazdin","year":"2011","journal-title":"Sci Transl Med"},{"key":"R46-7-20210129","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12185-010-0555-3","article-title":"Essential roles of VLA-4 in the hematopoietic system.","volume":"91","author":"Imai","year":"2010","journal-title":"Int J Hematol"},{"key":"R47-7-20210129","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm1114","article-title":". TCR affinity and negative regulation limit autoimmunity.","volume":"10","author":"Gronski","year":"2004","journal-title":"Nat Med"},{"key":"R48-7-20210129","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1182\/blood-2011-04-347252","article-title":". LFA-1 blockade induces effector and regulatory T-cell enrichment in lymph nodes and synergizes with CTLA-4Ig to inhibit effector function.","volume":"118","author":"Reisman","year":"2011","journal-title":"Blood"},{"key":"R49-7-20210129","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20062319","article-title":". Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation.","volume":"204","author":"Ford","year":"2007","journal-title":"J Exp Med"},{"key":"R50-7-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-6143.2011.03736.x","article-title":". Nondepleting Anti-CD40-Based Therapy Prolongs Allograft Survival in Nonhuman Primates.","volume":"12","author":"Badell","year":"2012","journal-title":"Am J Transplant"},{"key":"R51-7-20210129","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.4049\/jimmunol.0900339","article-title":". Anti-CD40 monoclonal antibody synergizes with CTLA4-Ig in promoting long-term graft survival in murine models of transplantation.","volume":"183","author":"Gilson","year":"2009","journal-title":"J Immunol"},{"key":"R52-7-20210129","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1470-2045(09)70161-5","article-title":". Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: A review from the Research on Adverse Drug Events and Reports (RADAR) project.","volume":"10","author":"Carson","year":"2009","journal-title":"Lancet Oncol"},{"key":"R53-7-20210129","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":". Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: Lessons from 28 cases.","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol"},{"key":"R54-7-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00228-009-0739-z","article-title":". Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents.","volume":"66","author":"Piccinni","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"R55-7-20210129","first-page":"271","article-title":"Progressive multifocal leukoencephalopathy: Can we reduce risk in patients receiving biological immunomodulatory therapies Ann N","volume":"68","author":"Tyler","year":"2010","journal-title":"eurol"},{"key":"R56-7-20210129","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2217\/imt.10.113","article-title":"Integrin antagonists for transplant immunosuppression: Panacea or peril I","volume":"3","author":"Kitchens","year":"2011","journal-title":"mmunotherapy"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-201205270-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:34:56Z","timestamp":1786048496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201205270-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,27]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e31824e75d7","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,27]]}}}